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Objective: The CCND1 gene expresses a protein, G1/S-
specific cyclin, that regulates the G1/S transition in the
cell cycle and also inhibits retinoblastoma (RB) proteins.
Overexpression or rearrangements of this gene can result
in various tumours. This study aimed to identify possible
deleterious non-synonymous single nucleotide poly-
morphisms (SNP’s) of CCND1 using computational
methods.
Methods: SNPs in the human CCND1 gene were
retrieved from dbSNP. These SNPs were screened by the
Sorting Intolerant From Tolerant (SIFT) algorithm and
the PredictSNP classification. Mutants with deleterious
SNPs were built using Discovery Studio 3.5, and dy-
namics studies were performed on native and mutant
varieties.
Results: In Homo sapiens, 1194 SNPs were found, of
which 94 were missense and 2 were nonsense SNPs. Three
SNPs were found to be deleterious. Molecular dynamics
and trajectory analysis showed that there was a significant
deviation of the root mean square deviation (RMSD)
values in the N216K mutant from the values of the native
protein.
Conclusion: Based on this study, we propose that the SNP
with SNP ID rs112525097 (NM_053056.2:c.648C>G)
might cause aberrations in CCND1, which might lead to a
change in the function of the G1/S-specific cyclin protein.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.07.009
ious single nucleotide polymorphisms and their effect on the sequence and
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Ple
strThis, in turn, may lead to the development of acute
myeloid leukaemia (AML).
Keywords: Acute myeloid leukaemia; CCND1; Molecular
dynamics; nsSNP; SIFT
 2016 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Many diseases have their genetic origins in single nucleo-
tide polymorphisms (SNPs). It has been a challenge to iden-
tify disease-causing SNPs in genes.1 Phenotypic variations
caused by SNPs also need to be studied.2 Non-synonymous
SNPs (nsSNP) alter DNA, regulate gene expression and
also cause changes in the resultant protein.3 The occurrence
of SNPs is roughly once every 1000e2000 bp,4 and there is
an estimated total of 150,482,731 newly released SNPs in
the human genome.5 Non-synonymous SNPs (nsSNPs) are
the cause of amino acid substitutions and are major factors
that contribute to the functional diversity of proteins. The
main aim of pharmacogenomics is to identify deleterious
SNPs. The gene that is the focus of our study, CCND1, is
present on chromosome 11 and has a coding sequence length
of 885 nucleotides. Its cytogenetic location is 11q13.3.6 This
gene codes for the protein G1/S-specific cyclin-D1, which is
a regulatory subunit of the cyclin D1-CDK4 complex.7 It
inhibits members of the retinoblastoma (RB) protein
family, such as RB1, by phosphorylation and also regulates
the cell-cycle during the G1/S transition phase. Cyclin D-
CDK4 complexes are translocated to the nucleus through
interactions with KIP/CIP family members after initially
accumulating at the nuclear membrane.8 Mutations,
amplification and overexpression of this gene can
contribute to tumourigenesis due to its role in regulating
cell cycle progression.9 When overexpressed, cyclin D1 acts
as an oncogene in many human neoplasias. Acute myeloid
leukaemia (AML) is a heterogeneous clonal disorder that is
characterized by clonal neoplastic cells that express
irrepressible proliferation. Blasts with an impaired
differentiation program accumulate in the bone marrow.10
Approximately 80% of all adult leukaemia is AML, which
is the most common cause of death from leukaemia.
Overall, of all people diagnosed with AML, approximately
20 of 100 people (20%) will survive for 5 years or more
after diagnosis. Younger people cope have a better
prognosis.11,12 Metastasis of abnormal white blood cells
results in leukaemic infiltration of the bone marrow,
resulting in cytopaenia. This leads to reduced red blood
cells, which causes fatigue in patients. A decrease in
platelets results in internal haemorrhage. Pallor and
infection due to a reduced normal white cell count is
common. There can be leukaemic infiltration to other
organs, which can cause abnormalities in these organs.13
Untreated AML is usually fatal within a few weeks or
months. Mutations in transcription factors that encode forase cite this article in press as: Yoganarasimha B, et al., Prediction of deleter
ucture of the human CCND1 gene, Journal of Taibah University Medical Scmyeloid differentiation can be found in patients with
AML.14 CCND1 binds and activates the G1 cyclin-
dependent kinases CDK4 and CDK6. The complex then in-
hibits members of the retinoblastoma (RB) family of pro-
teins. These processes regulate the G1/S transition in the cell
cycle.15 CCND1 promotes activation of cyclin E/CDK2-
containing complexes. It sequesters CDK inhibitors, such
as p27 Kip1 and p21Cip1, by a kinase-independent action.
CCND1 also inhibits the transcriptional activity and anti-
proliferative function of Smad3 by phosphorylation.16 This
gene has also been implicated in many other diseases, such
as multiple myeloma, Von Hippel-Lindau syndrome,
mantle cell lymphoma, chronic lymphocytic leukaemia, and
colorectal cancer, among others.
The aim of this study is to predict non-synonymous SNPs
in the CCND1 gene that might be responsible for causing
acute myeloid leukaemia. Mutations in this gene can lead to
its overexpression or non-regulation of the retinoblastoma
family of proteins (RB). In this study, we performed in silico
studies to identify deleterious SNPs in the CCND1 gene.
These SNPs might cause changes in the protein structure,
which can lead to changes in function. Using this informa-
tion, we have proposed modelled structures of the mutant
proteins. The stabilities of these structures were also checked.
These findings could be very helpful in the early diagnosis
and treatment of acute myeloid leukaemia. If the SNPs re-
ported in this study are experimentally verified to be a cause
of various cancers, foreknowledge of these mutations would
be of great help. Genetic screening can be performed, and
people with a particular mutation can be warned about the
risks posed by this mutation. These findings might lead to
therapeutic solutions, such as effective gene therapy, which
might be able to reduce the risk of cancer.
Materials and methods
The dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) data-
base was used to download SNPs and their related protein
sequences for in silico studies. Homology-based tools (SIFT
and PredictSNP) were used for the study of coding SNPs.
Determination of deleterious SNPs by SIFT and
PredictSNP
SIFT determines whether an amino acid substitution has
any effect on protein function. The degree of conservation of
amino acid residues obtained from the alignment of closely
related sequences is essential for the prediction of deleterious
SNPs. This technique can be used for predictions in naturally
occurring non-synonymous mutations or artificially induced
variations.17 Multiple SNP IDs were collected from the SNP
database of the NCBI and submitted as input queries. The
threshold value is a tolerance index of 0.05. The lower
the tolerance index, the greater is the functional effect of a
particular amino acid substitution. PredictSNP is a
consensus classifier that runs a suite of programs that are
usually used for the prediction of the effects of a mutation
on protein function. It combines the results of PredictSNP,
MAPP, PhD-SNP, PolyPhen-1, PolyPhen-2, SIFT, SNAP,
PANTHER and the nsSNPs analyser.18 The output
prediction value falls within the continuous interval ofious single nucleotide polymorphisms and their effect on the sequence and
iences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.07.009
Prediction of deleterious single nucleotide polymorphisms in CCND1 3(1,þ1). The effects of mutations are said to be neutral if the
value falls in the interval (1, 0). The mutations are
considered to be deleterious if they fall in the interval
(0, þ1). The greater the distance between the PredictSNP
score and zero, the more deleterious the mutations.
Multiple sequence alignment to determine conservation/
variation of the deleterious residues
FASTA sequences of the CCND1 protein of various or-
ganisms were retrieved from the UniProt database. The or-
ganisms were Homo sapiens, Mus musculus, Rattus
norvegicus and Pongo abelii. The UniProt identifiers are
P24385, P25322, P39948 and Q5R6J5, respectively. Multiple
sequence alignment was performed using CLC Genomics
Workbench software.19 The conservation/variation was
checked at the 130th and 216th residues.
Preparation of protein, stability check and molecular
dynamics
The protein, a crystal structure of CDK4 in complex with
a D-type cyclin with the PDB ID 2W96, was retrieved from
the PDB database.20 Because only the A-chain containing
CCND1 was required for this study, the B-chain containing
CDK4 was deleted. Other extra ligand molecules were also
deleted to stabilize the protein structure.21 The resulting
structure was considered to be the wild-type variety of the
protein. Mutational analysis was performed based on the
results obtained from the various tools that predicted dele-
terious mutations. The original amino acid residues were
replaced with mutant variants (N130D, N130S and
N216K).22 The mutated structures were optimized using
CHARMm force fields.23 They were subjected to a
standard dynamics cascade with a convergence energy of
0.001 kcal/mol.24 The optimized structures were then used
for further molecular simulation studies.25 In the mutant
variant NP_444284.1:p.Asn130Asp (N130D), A changes to
G at the 597th position in the mRNA (cDNA variation:
NM_053056.2:c.388A>G). Similarly, A changes to G at the
598th mRNA (c DNA variation: NM_053056.2:c.389A>G)
position in the mutant NP_444284.1:p.Asn130Ser (N130S).
In the NP_444284.1:p.Asn216Lys (N216K) variant, C
changes to G at the 857th mRNA position (cDNA
variation: NM_053056.2:c.648C>G). These polymorphisms
result in a single amino acid substitution in the protein,
which might result in changes in structure and function.Figure 1: Distribution of nsSNPs: frame shif
Please cite this article in press as: Yoganarasimha B, et al., Prediction of deleter
structure of the human CCND1 gene, Journal of Taibah University Medical ScThe stability of these mutations was tested by DUET and
SDM servers.26 The molecular dynamics simulation
protocol in Discovery Studio 3.5 was applied to the wild-
type and mutants derived from mutational studies. The tra-
jectory was analysed for a period of 6 ns with respect to
backbone atoms. The root mean square deviation is the
average inter-atomic distance of superimposed proteins. Six
thousand steps were performed in which every frame was
compared to the first frame and RMSD deviations were
calculated.27Results
Retrieval of SNPs from dbSNP
Investigations of the gene CCND1 were conducted, and
the variants of the gene were obtained from the dbSNP
database. A total of 1194 SNPs were found inHomo sapiens.
Of these, 89 encoding synonymous SNPs and 605 intron
SNPs were found. Two stop-gain and 2 frameshift SNPs were
found (Figure 1). The non-synonymous SNPs consisting of
94 missense SNPs and 2 nonsense SNPs were selected for
investigation. A large number of SNPs were in intron regions.Obtaining deleterious SNPs using SIFT and PredictSNP
The homology-based tool SIFT was used to determine the
conservation range of a particular amino acid. Ninety-six
nsSNPs were submitted to the SIFT tool. Their tolerance
indices were obtained. The lower the tolerance index, the
greater the effect of the amino acid substitution on the
function of the protein.17 The G1/S-specific cyclin-D1 pro-
tein sequence was downloaded from the UniProt database
(P24385).28 ProtParam29 analysis showed that the protein
has 295 amino acids. Its molecular weight is 33729.1 Da
and its theoretical PI is 4.97. The protein has 47 negatively
charged residues and 34 positively charged residues and an
instability index of 57.71, which classifies the protein as
unstable. The protein has an estimated half-life of 30 h in
humans and mammals. Among the 96 SNPs, 3 were pre-
dicted to be deleterious, with a score of less than or equal to
0.05. The results are presented below in Table 1. The SNPs of
SNPids rs1050971, rs1131439, and rs112525097 were found
to be damaging by the SIFT server. An SNP with a score
of 0.05 is predicted to be damaging. These mutations can
cause conformational changes in the protein, which is whyt, coding synonymous and intron SNPs.
ious single nucleotide polymorphisms and their effect on the sequence and
iences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.07.009
Table 1: Deleterious SNPs predicted by SIFT.
SNP ID Amino acid
change
Tolerance
Index
Prediction
rs1050971 N130D 0.01 Damaging
rs1131439 N130S 0.00 Damaging
rs112525097 N216K 0.05 Damaging
Note: Values less than or equal to a threshold of 0.05 are
considered to be damaging.
B. Yoganarasimha et al.4they were deemed to be deleterious by SIFT. The confidence
levels of structural alterations were obtained by using the
PredictSNP program. The protein sequences, along with
the mutations specified in the above SNPs, were submitted
as inputs, and the results obtained are depicted in Table 2.
PredictSNP is a consensus classifier. The mutations were
classified into two classes by all of the incorporated tools:
neutral or deleterious. An extra class of ‘possibly
deleterious’ was given by PolyPhen1. A confidence score
equal to 0.5 enabled this class to be considered a
deleterious class. The SNP p.Asn130Asp (N130D) was
found to be deleterious by MAPP and SIFT, with a
confidence score of 56 and 45 percent, respectively. The
SNP p.Asn130Ser (N130S) was found to be deleterious by
SIFT due to a confidence score of 53 percent. The SNP
p.Asn216Lys (N216K) was found to be deleterious by
PhD-SNP server due to a confidence score of 59 percent. It
can be observed that all of these confidence scores are below
the 60 percent mark. PredictSNP gives a higher score because
it combines the results of all of the analysis tools. The
p.Asn130Ser and p.Asn216Lys variations had similar scores.
The effects of their mutations were determined by molecular
dynamics studies.
Multiple sequence alignment to determine conservation/
variation of the deleterious residues
Multiple sequence alignment was performed to check
amino acid conservation/variation across species. In the
output, the rows correspond to the input sequences. The
columns correspond to the amino acid residue in the
respective positions. Gaps or positions with ʻ-ʼ indicate in-
sertions or deletions at that position. In this study, the se-
quences of human, mouse, rat and orangutan were aligned.
We observed that asparagine (N) was conserved at the 130th
and 216th positions in all 4 species, as shown in (Figure 2).
Therefore, we can conclude that this gene is an essential
gene that regulates key functions of the body.
Mutational studies of the protein and stability check
The wild-type protein was used, and mutants were built
based on the results predicted by SIFT and PredictSNP. ForTable 2: nsSNPs predicted to be functionally significant by PredictS
Mutation PredictSNP MAPP PhD-SNP PolyPh
N130D 65 56* 68 67
N130S 77 77 68 67
N216K 78 78 59* 67
Note: Scores less than 60 (indicated by *) have been flagged as ‘deleter
Please cite this article in press as: Yoganarasimha B, et al., Prediction of deleter
structure of the human CCND1 gene, Journal of Taibah University Medical Scthe mutant variant p.Asn130Asp, A was substituted for G at
the 597th mRNA position. The amino acid asparagine was
changed to aspartic acid. Similarly, A was changed to G at the
598th mRNA position in the mutant p.Asn130Ser. Here,
asparagine was changed to serine. In the p.Asn216Lys variant,
C was replaced with G at the 857th mRNA position. Aspara-
gine was changed to lysine in this variant (Figure 3). All 3
variants were subjected to a stability check by DUET and
SDM. The stability change is depicted in terms of the
variation in Gibb’s free energy. A negative energy variation is
said to be destabilizing, and a positive energy variation is said
to be stabilizing. The p.Asn130Ser variant had a variation
of 2.42 kcal/mol and 0.439 kcal/mol, as predicted by
SDM and DUET, respectively. The p.Asn130Asp variant
had a variation of 1.51 kcal/mol and 0.659 kcal/mol, as
predicted by SDM and DUET, respectively. The
p.Asn216Lys mutation had a variation of 0.23 kcal/mol
and 0.502 kcal/mol, as predicted by SDM and DUET,
respectively. All of the energy variations were negative.
Consequently, we can say that all 3 variations are destabilizing.Molecular dynamics simulation of the wild and mutant types
A comparative study of molecular dynamic properties was
conducted using the molecular dynamics simulation protocol
in Discovery Studio 3.5. This was conducted on the 3 mutant
variants and the native wild-type protein. The trajectory was
analysed for 6 ns. Different physico-chemical parameters,
such as the potential energy, electrostatic and root mean
square deviation, were calculated. The backbone RMSD
values were calculated from trajectory analysis. A graph of
RMSD versus trajectory time was prepared. The wild-type
protein was stable after a jump from 1.16 A˚ to 1.5 A˚ at
2 ns. The mutant p.Asn130Ser was generally stable in the
1.4e1.6 A˚ range after some distortion until reaching the
0.26 ns time period. The variant p.Asn130Asp was distorted
until 3.4 ns and then stabilized. The mutant p.Asn216Lys
showed amaximum deviation from the wild-type protein and
had a stable RMSD range of 1.6e1.8 A˚ (Figure 4). The
potential energy values were also calculated. It can be
observed that the p.Asn216Lys variant had the least final
potential energy of 14330.1 kcal/mol, whereas the wild-
type had a final potential energy of 13830.7 kcal/mol. The
p.Asn130Ser model had a final potential energy
of 13772.7 kcal/mol, and the p.Asn130Asp model had a
final potential energy of 14030 kcal/mol (Figure 5). There
was a significant deviation between the RMSD values of
the wild-type and the p.Asn216Lys model. Therefore, it can
be inferred that in the p.Asn216Lys variant, the protein un-
dergoes significant structural changes relative to the wild-
type protein. This might result in a change of function in
the mutated protein. This is also substantiated by the po-
tential energy studies, which show that the p.Asn216LysNP, in percentages.
en-1 PolyPhen-2 SIFT SNAP PANTHER
68 45* 61 64
63 53* 61 57
79 84 67 69
ious’ by the respective software.
ious single nucleotide polymorphisms and their effect on the sequence and
iences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.07.009
Figure 2: Multiple sequence alignment to determine conservation/variation of the deleterious residues.
Prediction of deleterious single nucleotide polymorphisms in CCND1 5model had the least potential energy, a difference of
499.4 kcal/mol from the potential energy of the wild-type.
This suggests that this mutated protein is highly stable and
is able to exist in natural in vivo conditions. This lends sup-
port to the inference that this mutation might have the ability
to cause a change in protein function and is stable enough to
be present for a long period of time.Discussion
The focus of this study was to analyse the CCND1 gene,
which codes for the G1/S-specific cyclin-D1 protein. This
protein is a regulatory subunit of the cyclin D1-CDK4
complex. It inhibits members of the retinoblastoma (RB)
protein family, such as RB1, by phosphorylation and also
regulates the cell-cycle during the G1/S transition phase. The
protein G1/S-specific cyclin-D1 belongs to the cyclin-C ter-
minal family (PF02984). During the cell cycle, the concen-
trations of these types of proteins vary in a cyclical manner.
The fluctuations in the expression of cyclin genes and
destruction by the proteasome complex, which is mediated
by ubiquitin targeting, drive the cell cycle by inducing fluc-
tuations in the activity of CDK proteins. Activation of CDK
is initiated by forming a complex with a cyclin protein, but
complete activation is achieved by phosphorylation. The
CDK active site is activated by complex formation. Cyclins
incorporate binding sites for some substrates. They have no
enzymatic properties, but lead the CDKs to particular sub-
cellular locations via targeting. DNA replication is induced
by a complex of S cyclin and CDK. High levels of S cyclins
are maintained throughout S phase, G2 phase and the early
mitosis stages. This helps to induce and promote the initial
activities of mitosis. Mutations or SNPs in CCND1might be
responsible for causing acute myeloid leukaemia or leading
to non-regulation of the retinoblastoma family of proteinsPlease cite this article in press as: Yoganarasimha B, et al., Prediction of deleter
structure of the human CCND1 gene, Journal of Taibah University Medical Sc(RB).30,31 DUET and SDM predict that the mutation is
destabilizing. We speculate that this might destabilize the
cyclinD1/CDK complex. This complex usually interacts
with Rb protein, a tumour suppressor. The mutated
CCND1 protein might result in a change in tumour
suppression, leading to the development of various tumours.
Here, we attempted to identify deleterious and destabi-
lizing SNPs in the CCND1 gene. We used an in silico
approach that collates the results of SIFT and PredictSNP
with those of Discovery Studio 3.5. In total, we identified 3
deleterious mutants. Further analysis confirmed that 2 mu-
tants were relatively stable. Briefly, investigations of the
CCND1 gene were conducted, and the analysis shows that
these SNPs do not affect protein function because they are
probably spliced out during mRNA generation.
Among the 96 nsSNPs submitted to SIFT and Predict
SNP, 3 SNPs (rs1050971, rs1131439, rs112525097) were
found to be deleterious based on their confidence score
(0.05). Further molecular dynamics simulation of the wild-
type and mutants were carried out for 3 mutant variants,
p.Asn130Asp (N130D), p.Asn130Ser (N130S) and
p.Asn216Lys (N216K), and the native wild-type protein.
This analysis showed that there is a significant deviation
between the RMSD values of the wild-type and the
p.Asn216Lys mutant model. This suggests that deviations in
the protein might be due to significant structural changes in
the mutants compared to the wild-type. Significant structural
modifications due to deviations in the RMSD values might
result in a change of function of the mutated protein.Conclusion
The CCND1 gene was investigated using in silicomethods.
A total of 1194 SNPs were found in humans. Of these, 89 were
synonymous and 96 were non-synonymous. The non-ious single nucleotide polymorphisms and their effect on the sequence and
iences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.07.009
Figure 3: Three experimentally validated nsSNPs [N130D, N130S and N216K].
B. Yoganarasimha et al.6synonymous SNPs included 94 missense SNPs and 2
nonsense SNPs. These 96 nsSNPs were analysed using SIFT
and PredictSNP. Three SNPs were found to be damaging by
SIFT, and this was corroborated by PredictSNP. The varia-
tion in structure caused by these mutations was studied by
molecular simulation studies for a time period of 6 ns. Of the
3 mutations identified in this study, it was found that the
mutation in the native protein at the 216th position, where
asparagine changes to lysine, had the largest deviation from
the RMSD value of the native structure. The native structurePlease cite this article in press as: Yoganarasimha B, et al., Prediction of deleter
structure of the human CCND1 gene, Journal of Taibah University Medical Schad an average RMSD value of 1.38, whereas the mutant
structure of the NP_444284.1:p.Asn216Lys (N216K) model
had an average RMSD value of 1.61. This can be interpreted
as the N216K model causing significant changes in structure,
which in turn might cause a significant change in function.
Hence, we can conclude that the nsSNP (rs112525097) asso-
ciated with this mutationmight be an important candidate for
the cause of acute myeloid leukaemia (AML) resulting from
the CCND1 gene. Further in vivo studies are required for
confirmation and development of therapeutic treatment.ious single nucleotide polymorphisms and their effect on the sequence and
iences (2016), http://dx.doi.org/10.1016/j.jtumed.2016.07.009
Figure 4: Backbone RMSDs are shown as a function of time for wild-type and mutant CCND1 protein structures over 6 ns.
Figure 5: Potential energy is shown as a function of time for wild-type and mutant CCND1 protein structures over 6 ns.
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